About Talphera
Talphera is a company based in San Mateo (United States). It operates as a HealthTech and Licensing Model. Talphera has completed 1 acquisition, including Lowell Therapeutics. Talphera offers products and services including Niyad™, LTX-608™, Fedsyra™, and PFS-02.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Talphera
Talphera offers a comprehensive portfolio of products and services, including Niyad™, LTX-608™, Fedsyra™, and PFS-02.
Regional anticoagulant developed for extracorporeal circuit in dialysis.
Investigated for anti-inflammatory and antiviral therapeutic applications.
Pre-filled syringe developed for hypotension treatment during anesthesia.
Pre-filled syringe created for hypotension and related conditions.
People of Talphera
Unlock access to complete
Unlock access to complete
Funding Insights of Talphera
Detailed funding history for Talphera
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Talphera
Talphera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lowell Therapeutics.
Investment portfolio details for Talphera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of anticoagulant for the treatment of acute kidney diseases
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Talphera
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Talphera
Detailed financials for Talphera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Talphera Comparisons
Peer comparison for Talphera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Talphera
Detailed competitors of Talphera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Talphera
Complete news archive for Talphera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Talphera
Talphera is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Innovative therapies and medical devices are developed and commercialized by Talphera for use in medically supervised settings. Focus is placed on improving patient outcomes through advanced tools for healthcare providers. Sectors include renal replacement therapy and acute care settings. Solutions such as Niyad, a regional anticoagulant for dialysis circuits, and pre-filled syringes like Fedsyra and PFS-02 are offered to enhance safety and efficiency. Additionally, LTX-608 is explored for anti-inflammatory and antiviral applications across various conditions.
Talphera offers Niyad™, LTX-608™, Fedsyra™, and PFS-02.
Talphera has made 1 acquisition, including Lowell Therapeutics.